COMMUNIQUÉS West-GlobeNewswire

-
Predictive Oncology to Report Second Quarter 2019 Financial Results and Provide Company Update on Monday, August 19, 2019
19/08/2019 -
OraSure Announces Sale of Cryosurgical Systems Business
19/08/2019 -
Oncology Pharma Signed a Letter of Intent with Kalos Therapeutics for an Exclusive World-Wide Licence and Co-Devlopent of Its Broad-Spectrum Anti-Cancer Drug, KTH 222
19/08/2019 -
Protech Home Medical Reports Solid Third Quarter Fiscal 2019 Financial Results
19/08/2019 -
Kiniksa to Present Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
19/08/2019 -
Alkahest Initiates Phase 2 Clinical and Mechanistic Trial of Postoperative Recovery Following Primary Hip or Knee Arthroplasty
19/08/2019 -
Enlivex Therapeutics Announces Positive Outcome From Safety Committee’s Review Of Six Patients With Severe Sepsis Patients; Enrollment Of Last Study Cohort Approved
19/08/2019 -
Auxly Enters Into a 300 Acre Hemp Cultivation and Purchase Agreement for the 2019 Cultivation Season
19/08/2019 -
VitalHub and Strata Health Announce Strategic Collaboration To Enhance Health and Social Service Provider System Efficiencies Globally
19/08/2019 -
The Joint Corp. Acquired Additional Clinic in the San Diego Market
19/08/2019 -
Fulcrum Therapeutics Announces Initiation of ReDUX4, a Phase 2b Clinical Trial of Losmapimod for FSHD
19/08/2019 -
Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors
19/08/2019 -
Transactions under Novozymes’ stock buyback program
19/08/2019 -
Philips unveils HeartStart Intrepid with IntelliSpace Connect across Europe and select markets worldwide
19/08/2019 -
Aino Health AB (publ): Decreased sick leave at Botkyrka Municipality with Aino Health
19/08/2019 -
NIH to Evaluate Iclaprim Activity against Listeria
19/08/2019 -
Vigil Reports Increased Sales Bookings in First Quarter
17/08/2019 -
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16/08/2019 -
Spineway : Defer of the the General Shareholders’ Meeting of August 16, 2019
16/08/2019
Pages